Top Abstract Purchase Related
Home
>
Node
>
Subnode

Managing HIV. Part 5: Treating secondary outcomes. 5.1 HIV and skin disease

Wong, D.; Shumack, S.

Medical Journal of Australia 164(6): 352-356

1996

ISSN/ISBN: 0025-729X
PMID: 8606661
Document Number: 457169
The skin is the largest and most visible organ of the body, and a perception of good health depends on its appearance as well as its function. As about 90% of HIV-infected patients develop cutaneous signs and symptoms, diagnosis and management are vital in recognising progression of HIV infection.

Document emailed within 1 workday
Secure & encrypted payments

McCluskey, P.J.; Hall, A.J.; Lightman, S. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.11 HIV and eye disease Medical Journal of Australia 164(8): 484-486
Frankum, B.S.; Savdie, E. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.10 HIV and renal disease Medical Journal of Australia 164(8): 483
Sievert, W.; Shaw, D.R.; Edwards, P. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.3 HIV, gastrointestinal and hepatobiliary disease Medical Journal of Australia 164(6): 360-365
Duflou, J.; Marriott, D. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.20 HIV and autopsies Medical Journal of Australia 164(10): 616-617
Hoy, J.F.; Marriott, D.; Gottlieb, T. 1996: Managing HIV. Part 5: Treating secondary outcomes. 5.15 HIV and non-tuberculous mycobacterial infection Medical Journal of Australia 164(9): 543-545
LeBeau, J. 2012: Laser technology: its role in treating and managing periodontal disease Compendium of Continuing Education in Dentistry 33(5): 370-371
Margolis, I.B.; Hayes, D.F. 1977: Managing peripheral vascular disease secondary to arteriosclerosis Geriatrics 32(6): 79-82
Carr, A.; Garsia, R. 1996: Managing HIV. Part 3: Mechanisms of disease. 3.5 how HIV leads to hypersensitivity reactions Medical Journal of Australia 164(4): 227-229
Ffrench, R.; Stewart, G.J.; Penny, R.; Levy, J.A. 1996: Managing HIV. Part 3. Mechanisms of disease. 3.2 how HIV produces immune deficiency Medical Journal of Australia 164(3): 166-171
Marriott, D.; McMurchie, M. 1996: Managing HIV. Part 2: Phases of disease. 2.4 HIV and advanced immune deficiency Medical Journal of Australia 164(2): 111-112
Kelleher, A.D.; Orth, D. 1996: Managing HIV. Part 2: Phases of disease. 2.2 Early HIV-induced immune deficiency Medical Journal of Australia 164(2): 107-108
Stewart, G.J.; Irvine, S.S.; Scott, M.; Kelleher, A.D.; Marriott, D.J.; McKnight, I.; Pethebridge, A.M.; Wodak, A.; Ziegler, J. 1996: Managing HIV. Part 1: Principles. 1.2 Strategies of care in managing HIV Medical Journal of Australia 164(2): 99-104
Levy, D.M.; Silverman, E.D.; Massicotte, M.Patricia.; McCrindle, B.W.; Yeung, R.S.M. 2005: Longterm outcomes in patients with giant aneurysms secondary to Kawasaki disease Journal of Rheumatology 32(5): 928-934
Kawecka-Jaszcz, K.; Pajak, A.; Jankowski, P. 2001: Krakow Program for Secondary Prevention of Ischaemic Heart Disease. Part I. Genesis and objectives Przeglad Lekarski 58(11): 953-955
Holding, S.; Russell, C.; Tyndall, K. 2013: Treating and managing atrial fibrillation Nursing Times 109(31-32): 16-19
Jenni, D.; Osterwalder, R.; Osswald, S.; Buser, P.; Pfisterer, M. 2001: Are we treating coronary heart disease and heart failure appropriately in the clinic and ambulatory care? Secondary prevention and drug therapy 1998 Praxis 90(41): 1759-1765
Friedrich, W. 1987: Possibilities for managing and treating sick children at child day care centers Zeitschrift für die Gesamte Hygiene und ihre Grenzgebiete 33(2): 80-82
Eliseev, O.M. 1991: The current principles of managing and treating pregnant women suffering from arterial hypertension. A lecture Terapevticheskii Arkhiv 63(10): 82-89
Harding, A.; Harland, K. 1995: Managing cleft lip and palate. Language outcomes are important Bmj 311(7017): 1432; Author Reply 1432-3
Kyle, G. 2007: A guide to managing constipation: Part two Nursing Times 103(19): 42-43